RecruitingPhase 1NCT05302531

Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome

Studying Short bowel syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Central Hospital, Nancy, France
Principal Investigator
Niasha MICHOT, MD
CHRU Nancy
Intervention
Amoxicillin(drug)
Enrollment
10 enrolled
Eligibility
18 years · All sexes
Timeline
2022 – 2025

Study locations (1)

Collaborators

Société Francophone Nutrition Clinique et Métabolisme · FIlière des Maladies rares Abdomino-THOraciques · Fresenius Kabi

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05302531 on ClinicalTrials.gov

Other trials for Short bowel syndrome

Additional recruiting or active studies for the same condition.

See all trials for Short bowel syndrome →

← Back to all trials